
Top Three Biotech Partnering Drivers for 2023
Biotech stocks have been beat up since February 2021, with the XBI index still down ~50% from record highs Headwinds in 2022 stemming...
Writing about topics in life science, especially in the biotechnology and pharmaceutical industries. I leverage my experience as a co-founder of a biotechnology start-up to discuss tactical and strategic considerations for scaling a business, as well as external market and fundraising implications.